Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth MacDonald

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|July 19, 2020
LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse ModelSadia Mehdi, Elizabeth Macdonald, Kristianne Galpin, et al.
JAAD Case Reports|November 15, 2023
Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosisNicole Trepanowski, Rebecca M Yim, Rachel Wetstone, et al.
Oncotarget|February 13, 2016
The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cellsAdnen Faddaoui, Magdalena Bachvarova, Marie Plante, et al.
Biology of Reproduction|November 28, 2022
SWI/SNF chromatin remodeling subunit Smarca4/BRG1 is essential for female fertility†Atefeh Abedini, David A Landry, Angus D Macaulay, et al.
Oncotarget|September 16, 2015
BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolismZhi-Qiang Wang, Adnen Faddaoui, Magdalena Bachvarova, et al.
Oncotarget|November 16, 2017
Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent mannerRazan Sheta, Zhi-Qiang Wang, Magdalena Bachvarova, et al.
Frontiers in Immunology|January 18, 2024
NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigensGalaxia M Rodriguez, Edward Yakubovich, Humaira Murshed, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|October 19, 2023
The Aging Care 5Ms Competencies: A Modified Delphi Study to Revise Medical Student Competencies for the Care of Older AdultsThirumagal Yogaparan, Alishya Burrell, Catherine Talbot-Hamon, et al.
Journal of Biophotonics|November 27, 2021
Multispectral label-free Raman spectroscopy can detect ovarian and endometrial cancer with high accuracySandryne David, Arthur Plante, Frédérick Dallaire, et al.
Scientific Reports|January 9, 2024
FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer modelsKristianne J C Galpin, Galaxia M Rodriguez, Vincent Maranda, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|July 19, 2020
LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse ModelSadia Mehdi, Elizabeth Macdonald, Kristianne Galpin, et al.
JAAD Case Reports|November 15, 2023
Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosisNicole Trepanowski, Rebecca M Yim, Rachel Wetstone, et al.
Oncotarget|February 13, 2016
The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cellsAdnen Faddaoui, Magdalena Bachvarova, Marie Plante, et al.
Biology of Reproduction|November 28, 2022
SWI/SNF chromatin remodeling subunit Smarca4/BRG1 is essential for female fertility†Atefeh Abedini, David A Landry, Angus D Macaulay, et al.
Oncotarget|September 16, 2015
BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolismZhi-Qiang Wang, Adnen Faddaoui, Magdalena Bachvarova, et al.
Oncotarget|November 16, 2017
Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent mannerRazan Sheta, Zhi-Qiang Wang, Magdalena Bachvarova, et al.
Frontiers in Immunology|January 18, 2024
NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigensGalaxia M Rodriguez, Edward Yakubovich, Humaira Murshed, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|October 19, 2023
The Aging Care 5Ms Competencies: A Modified Delphi Study to Revise Medical Student Competencies for the Care of Older AdultsThirumagal Yogaparan, Alishya Burrell, Catherine Talbot-Hamon, et al.
Journal of Biophotonics|November 27, 2021
Multispectral label-free Raman spectroscopy can detect ovarian and endometrial cancer with high accuracySandryne David, Arthur Plante, Frédérick Dallaire, et al.
Scientific Reports|January 9, 2024
FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer modelsKristianne J C Galpin, Galaxia M Rodriguez, Vincent Maranda, et al.
Pageof 4